A concentration tells how much drug is in a given volume. Every problem in this topic becomes easy once the concentration is written as amount per mL (mg/mL, mcg/mL, units/mL, mEq/mL).
Three ways strength is written
| Expression | Meaning | Convert to per mL |
|---|
| Percent (w/v) | grams per 100 mL | 5% = 5 g/100 mL = 50 mg/mL; 0.9% = 0.9 g/100 mL = 9 mg/mL |
| Ratio (1:X) | 1 g in X mL | 1:1,000 = 1 mg/mL; 1:10,000 = 0.1 mg/mL |
| Amount per volume | mg/mL, units/mL, and so on | Already per mL |
Concentration of a mixed infusion = total drug in the bag ÷ total volume in the bag. For example, heparin 25,000 units in 500 mL = 50 units/mL.
Dilution (C1 × V1 = C2 × V2). When a solution is diluted, the amount of drug does not change. C1 and V1 are the starting concentration and volume; C2 and V2 are the final ones. Diluent to add = V2 − V1.
Titrated infusion formulas
| Order written as | mL/h formula |
|---|
| units/h or mg/h | Dose per hour ÷ concentration per mL |
| mcg/min | (mcg/min × 60) ÷ mcg/mL |
| mcg/kg/min | (mcg/kg/min × kg × 60) ÷ mcg/mL |
| units/kg/h | (units/kg/h × kg) ÷ units/mL |
To find the dose a running pump is delivering, reverse the formula: mcg/kg/min = (mL/h × mcg/mL) ÷ (kg × 60).
Rounding: infusion pump rates are commonly set to tenths of a mL/h on smart pumps; follow the pump and policy. The most common error is a missed mg → mcg conversion (× 1,000).
Concentration and titration calculations are used for continuous high-alert infusions and for drugs supplied in percent or ratio strengths.
| Drug | Typical use | Key safety points |
|---|
| Heparin (unfractionated) | VTE treatment, acute coronary syndrome | Bleeding, heparin-induced thrombocytopenia (check platelets); aPTT (about 1.5–2.5 × control) or anti-Xa (commonly 0.3–0.7 units/mL) per protocol; antidote protamine sulfate |
| Regular insulin IV | DKA, hyperglycemic hyperosmolar state, critical illness | Hypoglycemia and hypokalemia; check potassium before starting; hourly glucose |
| Norepinephrine (prototype vasopressor) | Septic shock (first-line, target MAP 65 mmHg or higher) | Tachydysrhythmias, hypertension, limb and gut ischemia; extravasation → tissue necrosis, treat with phentolamine; may be started through a peripheral IV in a large proximal vein with at least hourly site checks per protocol; central line preferred for prolonged use or rising doses |
| Dopamine | Hypotension or symptomatic bradycardia in selected clients | Tachydysrhythmias (more than norepinephrine), extravasation (phentolamine); dangerous with MAO inhibitors |
| Epinephrine | Anaphylaxis (IM), cardiac arrest (IV), infusion for shock | 1 mg/mL for IM; 0.1 mg/mL for IV push in arrest — the wrong strength by the wrong route causes severe hypertension and dysrhythmias |
| Magnesium sulfate | Preeclampsia with severe features, hypomagnesemia, torsades | Loss of reflexes, respiratory depression, cardiac arrest in toxicity; antidote calcium gluconate; renal excretion |
Worked examples
Example 1 — percent and ratio strengths.
- Grams of dextrose in 500 mL of D10W: 10 g/100 mL × 500 mL = 50 g
- Anaphylaxis: epinephrine 0.5 mg IM. Available: 1 mg/mL (formerly labeled 1:1,000). (0.5 ÷ 1) × 1 mL = 0.5 mL into the mid-outer thigh.
- Cardiac arrest: epinephrine 1 mg IV. Available: 0.1 mg/mL prefilled syringe (formerly 1:10,000). (1 ÷ 0.1) × 1 mL = 10 mL.
- Check: 1:1,000 means 1 g/1,000 mL = 1,000 mg/1,000 mL = 1 mg/mL; 1:10,000 is ten times weaker.
Example 2 — percent strength and dilution (C1V1 = C2V2). Order: magnesium sulfate 4 g IV. Available: 50% vial. For IV use the drug must be diluted to 20% or less.
- 50% = 50 g/100 mL = 0.5 g/mL (500 mg/mL)
- Volume of 50%: 4 g ÷ 0.5 g/mL = 8 mL
- Dilute to 20%: 50% × 8 mL = 20% × V2 → V2 = 400 ÷ 20 = 20 mL final volume
- Diluent to add: 20 − 8 = 12 mL
- Check: 4 g in 20 mL = 0.2 g/mL = 20%. In practice, use a premixed bag from pharmacy whenever available (ISMP high-alert drug), on a pump — for preeclampsia, a 4–6 g loading dose over 20–30 minutes, then 1–2 g/h — with reflexes, respirations, and urine output monitored.
Example 3 — mcg/kg/min to mL/h. Order: dopamine 5 mcg/kg/min. Weight 70 kg. Bag: dopamine 400 mg in 250 mL.
- Concentration: 400 mg ÷ 250 mL = 1.6 mg/mL = 1,600 mcg/mL
- Dose per minute: 5 × 70 = 350 mcg/min
- Dose per hour: 350 × 60 = 21,000 mcg/h
- Rate: 21,000 ÷ 1,600 = 13.125 → 13.1 mL/h
- Dimensional analysis: 5 mcg/kg/min × 70 kg × 60 min/h × 1 mg/1,000 mcg × 250 mL/400 mg = 13.125 mL/h. Same answer.
Example 4 — reverse calculation and titration. Norepinephrine 4 mg in 250 mL is running at 30 mL/h. The order: titrate by 2 mcg/min every 5 minutes to keep MAP 65 mmHg or higher.
- Concentration: 4 mg ÷ 250 mL = 0.016 mg/mL = 16 mcg/mL
- Current dose: 30 mL/h × 16 mcg/mL = 480 mcg/h ÷ 60 = 8 mcg/min
- MAP is 58, so increase to 10 mcg/min: 10 × 60 = 600 mcg/h ÷ 16 = 37.5 mL/h
- Check: 37.5 × 16 = 600; 600 ÷ 60 = 10 mcg/min.
Example 5 — weight-based heparin. Weight 80 kg. Protocol (one common VTE nomogram): bolus 80 units/kg, then 18 units/kg/h. Bolus vial: 1,000 units/mL. Bag: 25,000 units in 500 mL.
- Bolus: 80 × 80 = 6,400 units → 6,400 ÷ 1,000 = 6.4 mL
- Infusion: 18 × 80 = 1,440 units/h
- Concentration: 25,000 ÷ 500 = 50 units/mL
- Rate: 1,440 ÷ 50 = 28.8 mL/h
- Six hours later, the aPTT is low and the protocol says "rebolus 40 units/kg and increase by 2 units/kg/h": rebolus 40 × 80 = 3,200 units (3.2 mL); new rate 20 × 80 = 1,600 units/h ÷ 50 = 32 mL/h.
- Doses and limits differ by protocol (acute coronary syndrome protocols use lower doses with maximums); always use your facility's nomogram.
Example 6 — insulin infusion. DKA; weight 65 kg; order 0.1 units/kg/h. Bag: regular insulin 100 units in 100 mL 0.9% sodium chloride.
- Concentration: 100 units ÷ 100 mL = 1 unit/mL
- Dose: 0.1 × 65 = 6.5 units/h
- Rate: 6.5 ÷ 1 = 6.5 mL/h
- Before starting: potassium must be at least 3.5 mmol/L (mEq/L); if lower, replace potassium and delay insulin. Monitor glucose hourly.
- Wrong concentration chosen (two bag strengths, or 1 mg/mL epinephrine given IV instead of 0.1 mg/mL) → severe overdose
- mg/mcg conversion missed → thousandfold error in vasoactive drugs
- Weight-based order calculated with lb → 2.2-fold overdose
- Drug-specific: heparin → bleeding and HIT; insulin → hypoglycemia and hypokalemia; vasopressors → dysrhythmias, hypertension, tissue ischemia; magnesium → respiratory depression and cardiac arrest
- Use standard concentrations and the smart-pump drug library; avoid programming outside the library ("basic mode").
- Vasoactive infusions: dedicated line or port; a peripheral start in a large proximal vein is acceptable per protocol (do not delay therapy waiting for central access), with a central line preferred for prolonged use; never flush a line containing a vasopressor (the drug in the line becomes a bolus); do not stop abruptly — wean as ordered.
- Heparin: caution with active bleeding, recent surgery, low platelets, or history of HIT (use a non-heparin anticoagulant); interacts with antiplatelets, NSAIDs, and other anticoagulants.
- Insulin infusion: do not start with potassium below 3.5 mmol/L; add dextrose as glucose falls per protocol.
- Dopamine: avoid with MAO inhibitors (hypertensive crisis).
- Magnesium: contraindicated in myasthenia gravis; reduce with kidney impairment; potentiates neuromuscular blockers.
- Ratio labels: US single-drug injectable labels now show mg/mL; ratio expressions persist in local anesthetic–epinephrine combinations (for example, lidocaine with epinephrine 1:100,000) and in older references.
Listed in priority order.
- Hemodynamic and respiratory monitoring for titrated vasoactive drugs — continuous ECG and frequent or continuous blood pressure (often arterial line), MAP against the ordered target, perfusion, urine output.
- Independent double check of drug, concentration, dose, weight, pump programming, and line before starting, at every rate change, and at handoff.
- Titrate only within the ordered parameters (dose range, step size, interval, target); document each change with the client's response.
- Check the IV site frequently for vasopressor extravasation; if it occurs, stop the infusion, leave the catheter in place initially, and notify for phentolamine per protocol.
- Laboratory monitoring: aPTT or anti-Xa and platelets (heparin), hourly glucose and potassium (insulin), magnesium level with reflexes and respirations (magnesium).
- Label each bag and line with drug and concentration; trace lines from bag to client.
- Explain continuous monitoring and why alarms sound; ask the client not to touch pump controls.
- Heparin: report bleeding gums, blood in urine or stool, and new bruising; use a soft toothbrush.
- Insulin infusion: report shakiness, sweating, confusion, or hunger (hypoglycemia).
- Report pain, burning, or swelling at the IV site at once.
| Drug | Overdose picture | Antidote / response |
|---|
| Heparin | Bleeding | Stop infusion; protamine sulfate (slowly — hypotension, anaphylaxis) |
| Insulin | Hypoglycemia, hypokalemia | Stop or reduce infusion; IV dextrose; potassium replacement |
| Norepinephrine, dopamine | Hypertension, dysrhythmias; extravasation necrosis | Reduce or stop per order; phentolamine infiltration for extravasation |
| Epinephrine (wrong strength IV) | Severe hypertension, ventricular dysrhythmias, pulmonary edema | Supportive care; notify immediately |
| Magnesium sulfate | Lost patellar reflexes, respirations under 12/min, cardiac arrest | Stop infusion; calcium gluconate 10%, 10 mL (1 g) IV slowly |
- Always convert strength to per mL first
- Percent = g/100 mL (5% = 50 mg/mL; 0.9% NaCl = 9 mg/mL)
- 1:1,000 = 1 mg/mL (IM anaphylaxis); 1:10,000 = 0.1 mg/mL (IV arrest)
- C1V1 = C2V2; diluent to add = V2 − V1
- mcg/kg/min → mL/h: dose × kg × 60 ÷ mcg/mL
- Reverse: mcg/kg/min = mL/h × mcg/mL ÷ (kg × 60)
- Heparin 25,000 units/500 mL = 50 units/mL; 25,000 units/250 mL = 100 units/mL
- Insulin 100 units/100 mL = 1 unit/mL → units/h equals mL/h
- Check potassium (3.5 mmol/L or higher) before an insulin infusion
- Never flush a vasopressor line; extravasation → phentolamine
Country Notes
United States
- Since the USP labeling standard became official on May 1, 2016, single-entity injectable products such as epinephrine are labeled in mg/mL (1 mg/mL, 0.1 mg/mL) rather than ratios; older references and combination local anesthetics still show ratios.
- Many hospitals use standardized concentrations for high-alert infusions within smart-pump libraries.
Philippines
- Epinephrine is commonly called adrenaline, and some products and references may still show ratio strengths — convert to mg/mL before calculating.
- Where pumps are limited, high-alert infusions may be run with microdrip sets or volume-control chambers; the same mL/h calculation applies, and with a 60 gtt/mL set, gtt/min equals mL/h.